Safety and Immunogenicity of a Recombinant Adenovirus Type-5–Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

Publication | Open Access

DOI Full Paper Access

102

Citations

References

2021

Year

Fengcai Zhu, Pengfei Jin, Tao Zhu, Wenjuan Wang, Huayue Ye, Hongxing Pan, Lihua Hou, Jingxin Li, Xue Wang, Shipo Wu,

Clinical Infectious Diseases

Abstract

References